Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mind Medicine Inc shares valued at $78,139 were sold by Sullivan Mark on Jun 25 ’25. At $6.80 per share, Sullivan Mark sold 11,491 shares. The insider’s holdings dropped to 305,130 shares worth approximately $2.06 million following the completion of this transaction.
Also, Karlin Daniel sold 7,848 shares, netting a total of over 53,366 in proceeds. Following the sale of shares at $6.80 each, the insider now holds 438,329 shares.
Before that, Barrow Robert had sold 26,491 shares from its account. In a trade valued at $180,139, the Chief Executive Officer traded Mind Medicine Inc shares for $6.80 each. Upon closing the transaction, the insider’s holdings decreased to 26,491 shares, worth approximately $5.59 million.
As published in their initiating research note from Evercore ISI on January 28, 2025, Mind Medicine Inc [MNMD] has been an Outperform and the price target has been revised to $23. Analysts at Chardan Capital Markets started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. Earlier on July 24, 2024, ROTH MKM initiated its rating. Their recommendation was “a Buy” for MNMD stock.
Analyzing MNMD Stock Performance
On last trading session,, Mind Medicine Inc [NASDAQ: MNMD] plunged -1.46% to $6.74. The stock’s lowest price that day was $6.661, but it reached a high of $6.9299 in the same session. During the last five days, there has been a drop of approximately -4.94%. Over the course of the year, Mind Medicine Inc shares have dropped approximately -8.67%. Shares of the company reached a 52-week high of $10.44 on 02/14/25 and a 52-week low of $4.70 on 04/09/25.
Support And Resistance Levels for Mind Medicine Inc (MNMD)
According to the 24-hour chart, there is a support level at 6.62, which, if violated, would cause prices to drop to 6.51. In the upper region, resistance lies at 6.89. The next price resistance is at 7.05. RSI (Relative Strength Index) is 44.59 on the 14-day chart, showing neutral technical sentiment.
Is Mind Medicine Inc subject to short interest?
Stocks of Mind Medicine Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.43 million shares to 11.07 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 11.5 million shares. A decline of -3.9% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.07 of the overall float, the days-to-cover ratio (short ratio) decline to 9.07.
Which companies own the most shares of Mind Medicine Inc (MNMD)?
In terms of Mind Medicine Inc share price expectations, FactSet research, analysts set an average price target of 16 in the next 12 months, up nearly 133.92% from the previous closing price of $6.84. Analysts anticipate Mind Medicine Inc stock to reach 16 by 2025, with the lowest price target being 16. In spite of this, 2 analysts ranked Mind Medicine Inc stock as Buy at the end of 2025. On May 29, 2024, Robert W. Baird assigned a price target of “an Outperform” to the stock and initiated coverage with a $27.
